CUBIST PHARMACEUTICALS INC (CBST) has 146 open-market insider trades by 20 insiders since 2006. The most active filer is Robert J. Perez, CEO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Michael W. Bonney | CEO | — | 13 | $27.1M | 2015-01-21 |
| Robert J. Perez | CEO | — | 27 | $15.5M | 2015-01-21 |
| Steven C. Gilman | EVP & Chief Scientific Officer | — | 17 | $14.2M | 2015-01-21 |
| Gregory Stea | SVPCommercial Operations | — | 26 | $13.6M | 2014-09-30 |
| David W. J. McGirr | CFO | — | 9 | $6.3M | 2013-02-16 |
| Martin Rosenberg | Dir | — | 7 | $3.3M | 2013-09-09 |
| Kenneth Bate | Dir | — | 6 | $2.5M | 2015-01-21 |
| J. Matthew Singleton | Dir | — | 8 | $2.3M | 2013-06-06 |
| Santosh Vetticaden | SVP & Chief Medical Officer | — | 2 | $2.1M | 2011-12-30 |
| Nancy J. Hutson | Dir | — | 7 | $1.6M | 2015-01-21 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Steven C. Gilman | EVP & Chief Scientific Officer | Sell | $3.1M | 2014-10-01 |
| Gregory Stea | SVP & Commercial Operations | Sell | $2.5M | 2014-08-19 |
| Nancy J. Hutson | Director | Sell | $585K | 2014-08-18 |
| Robert J. Perez | President | Sell | $64K | 2014-08-18 |
| Michael John Tomsicek | CFO | Sell | $26K | 2014-08-18 |
| Steven C. Gilman | EVP & Chief Scientific Officer | Sell | $2.5M |
Companies that share insiders with CBST, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2014-07-28 |
| Steven C. Gilman | EVP & Chief Scientific Officer | Sell | $1.1M | 2014-05-15 |
| Gregory Stea | SVP & Commercial Operations | Sell | $59K | 2014-05-15 |
| Michael W. Bonney | CEO | Sell | $205K | 2014-05-15 |
| Robert J. Perez | President | Sell | $102K | 2014-05-15 |
| Steven C. Gilman | EVP & Chief Scientific Officer | Sell | $116K | 2014-05-14 |
| Gregory Stea | SVP & Commercial Operations | Sell | $60K | 2014-05-14 |
| Michael John Tomsicek | CFO | Sell | $34K | 2014-05-14 |
| Robert J. Perez | President | Sell | $166K | 2014-05-14 |
| Michael W. Bonney | CEO | Sell | $265K | 2014-05-14 |